Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism NPRA agonists(Natriuretic peptide receptor 1 agonists), NPRC agonists(Natriuretic peptide receptor 3 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiomyopathy, Hypertrophic | Preclinical | US | - | |
Fibrosis | Preclinical | US | - |